comparemela.com

Latest Breaking News On - Oswaldo cruz institute fiocruz - Page 1 : comparemela.com

New SARS-CoV-2 lineage has spread across many Brazilian states

New SARS-CoV-2 lineage has spread across many Brazilian states Researchers in Brazil have identified the emergence of a new lineage of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Brazil that has spread across multiple states in the country. The SARS-CoV-2 virus is the agent responsible for the coronavirus disease 2019 (COVID-19) that continues to pose a threat to global public health and the worldwide economy. Marilda Siqueira from the Oswaldo Cruz Institute (Fiocruz) in Rio de Janeiro and colleagues say this new variant of interest (VOI) probably emerged in August 2020 and is already widely distributed in Brazil. Designated as N.9, the variant emerged in the B.1.1.33 lineage and comprised 35% of all B.1.1.33 sequences detected between November 2020 and February 2021.

Brazil will receive supplies to produce Oxford s COVID-19 vaccines

Brazil will receive supplies to produce Oxford s COVID-19 vaccines Brazil will receive supplies to produce Oxford s COVID-19 vaccines Brasilia, Feb 27 (Prensa Latina) The Government of Brazil will receive on Saturday raw material to produce 12 million Covid-19 vaccines developed by the University of Oxford (United Kingdom) and the Anglo-Swedish company AstraZeneca in a national laboratory. The so-called Active Pharmaceutical Ingredients (API) manufactured by the Wuxi Biologics laboratory, in China, will be stored at the Oswaldo Cruz Institute (Fiocruz), in Rio de Janeiro, the Ministries of Health and Foreign Relations reported. This will be the second batch of APIs arriving in the country to produce the AstraZeneca vaccine. Brazil received from China the first batch of ingredient on January 6th.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.